Los Angeles to Host SNMMI 2026

News | SNMMI | April 07, 2026

The Society of Nuclear Medicine and Molecular Imaging’s annual meeting is set to convene in Los Angeles at the end of May.

The Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los Angeles, California.

SNMMI brings together global leaders to present the latest research and advances shaping clinical care in nuclear medicine, molecular imaging and theranostics.

The meeting will feature:

  • New research in theranostics and oncology, cardiology and neuroscience

  • New developments in imaging technology and instrumentation

  • Clinical applications impacting diagnosis, treatment, and patient management

  • A sold-out exhibit hall highlighting the latest innovations

Click here to access the entire conference agenda.


molecular imaging, nuclear imaging, Alzheimer's, brain

News | PET Imaging

Catalyst MedTech Establishes Full Access Neurology Solution for Brain PET Implementation in the U.S.

March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is …

timeApril 06, 2026
MRI, CT, molecular, interventional

News | Radiology Imaging

GE HealthCare, Stanford Radiology Expand Collaboration; Create Center of Excellence  

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of …

timeMarch 30, 2026
MRI, cardiac imaging, AI

News | Magnetic Resonance Imaging (MRI)

Study: AI Model Can Read Cardiac MRI Scans with Near Expert Accuracy

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets …

timeMarch 26, 2026
scholarship, imaging, john patrick university

News | Radiology Education

Center for Radiology Education to Provide Medical Imaging Scholarships at John Patrick University

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* …

timeMarch 17, 2026
chest, x-ray, FDA, lung, Qure.ai

News | FDA

FDA Clears Six Indications for Qure.ai’s Chest X-Ray Reporting Tool

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the …

timeFebruary 26, 2026
ARRS Roentgen Cardio Research

News | ARRS

ARRS Roentgen Fund Announces Research Awards for Neuroradiology, Cardiothoracic 

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their …

timeFebruary 13, 2026
Professional Groups Call for a Unified Effort Unlock Modern Radiation Oncology’s Full Potential

News | Radiation Therapy

Professional Groups Call for Unified Effort Unlock Modern Radiation Oncology’s Full Potential

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European …

timeFebruary 04, 2026
U.K. Cancer Doctors Respond to Cancer Plan for England

News | Radiology Imaging

Royal College of Radiologists Responds to U.K. Cancer Plan

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government’s …

timeFebruary 04, 2026
FDA Clears GE HealthCare's MIM LesionID Pro

News | FDA

FDA Clears GE HealthCare’s AI-powered Tumor Burden Analysis Tool

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM …

timeFebruary 03, 2026
Allia Moveo Platform from GE Healthcare Receives FDA Clearance, CE Mark

News | Interventional Radiology

Allia Moveo Platform from GE Healthcare Receives FDA Clearance, CE Mark

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) …

timeFebruary 02, 2026

 

Latest articles

Related articles